Showing posts from September, 2023Show all
Media Update: Sanofi completes acquisition of Qunol® health-issue

Media Update: Sanofi completes acquisition of Qunol®

Nitesh sinha September 29, 2023

https://ift.tt/O0Bucov   from Sanofi - Aventis Groupe https://ift.tt/odI4GgF via IFTTT

Read more
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review health-issue

Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review

Nitesh sinha September 26, 2023

https://ift.tt/CaX3Wey   from Sanofi - Aventis Groupe https://ift.tt/GFrXNxS via IFTTT

Read more
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A health-issue

Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

Nitesh sinha September 25, 2023

https://ift.tt/yNkC2Ia   from Sanofi - Aventis Groupe https://ift.tt/IVwDCNz via IFTTT

Read more
Press Release: Availability of the Q3 2023 Memorandum for modelling purposes health-issue

Press Release: Availability of the Q3 2023 Memorandum for modelling purposes

Nitesh sinha September 22, 2023

https://ift.tt/9m0a7dx from Sanofi - Aventis Groupe https://ift.tt/9ZJvdn6 via IFTTT

Read more
Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change health-issue

Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change

Nitesh sinha September 19, 2023

https://ift.tt/Asxqt08   from Sanofi - Aventis Groupe https://ift.tt/dBNUwZm via IFTTT

Read more
Media Update: New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMD health-issue

Media Update: New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMD

Nitesh sinha September 14, 2023

https://ift.tt/IGU20bz New data at ERS showed Xenpozyme ® ( olipudase alfa) improved respiratory functions in adults with ASMD from Sanof…

Read more
Media Update: New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions  health-issue

Media Update: New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions 

Nitesh sinha September 05, 2023

https://ift.tt/OoNYmTE New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditi…

Read more